NDC 24979-710

Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)

Paclitaxel

Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) is a Intravenous Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Twi Pharmaceuticals, Inc.. The primary component is Paclitaxel.

Product ID24979-710_1f41135d-3da4-45b2-9462-6482256fa728
NDC24979-710
Product TypeHuman Prescription Drug
Proprietary NamePaclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
Generic NamePaclitaxel
Dosage FormInjection, Powder, Lyophilized, For Suspension
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-04-01
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA021660
Labeler NameTWi Pharmaceuticals, Inc.
Substance NamePACLITAXEL
Active Ingredient Strength100 mg/20mL
Pharm ClassesMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 24979-710-51

1 VIAL, SINGLE-USE in 1 CARTON (24979-710-51) > 20 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2022-04-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)" or generic name "Paclitaxel"

NDCBrand NameGeneric Name
24979-710Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)Paclitaxel
0703-3213PaclitaxelPaclitaxel
0703-3216PaclitaxelPaclitaxel
0703-3217PaclitaxelPaclitaxel
0703-3218PaclitaxelPaclitaxel
0703-4764PaclitaxelPaclitaxel
0703-4766PaclitaxelPaclitaxel
0703-4767PaclitaxelPaclitaxel
0703-4768PaclitaxelPaclitaxel
16714-137PaclitaxelPaclitaxel
16729-098PaclitaxelPACLITAXEL
44567-504PaclitaxelPaclitaxel
44567-505PaclitaxelPaclitaxel
44567-506PaclitaxelPaclitaxel
45963-613PaclitaxelPaclitaxel
47781-593Paclitaxelpaclitaxel

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.